Atlas Trials

The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment

Clinical trial NCT06810492 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06810492
Sponsor
Hongmei Zheng, PhD
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer Stage IIIBreast Cancer Stage II
Start date
2025-04-01
Primary completion
2025-12-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.